Hubei Jumpcan Pharmaceutical Co., Ltd Class ASSE: 600566

"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Implementation of Self-exercise for the Second Exercise Period of Stock Options of the Initial Grant under the 2022 Restricted Share and Stock Option Incentive Plan

Sep 25, 2026 · Issued by Hubei Jumpcan Pharmaceutical Co., Ltd Class A via Shanghai Stock Exchange

Filed with SSE · Sep 25, 2026

Announcement on Implementation of Self-exercise for the Second Exercise Period of Stock Options of the Initial Grant under the 2022 Restricted Share and Stock Option Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Hubei Jumpcan Pharmaceutical Co., Ltd Class A

"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Lifting of Restrictions and Listing of Restricted Shares of the Initial Grant for the Second Lifting Period under the 2022 Restricted Share and Stock Option Incentive PlanSep 22
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Completion of Cancellation of Certain Stock Options under the 2022 Restricted Share and Stock Option Incentive PlanSep 18
"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Certain DirectorsSep 2
"Hubei Jumpcan Pharmaceutical Co., Ltd."Special Report on the Deposit and Actual Use of Raised Funds for the First Half of 2026Aug 29

All Hubei Jumpcan Pharmaceutical Co., Ltd Class A news releases